Results 11 to 20 of about 77,099 (293)

Toxicology of Psychoactive Substances

Critical Care Clinics, 2021
A trend in the increasing use of prescription psychoactive drugs (PADs), including antidepressants, antipsychotics, and mood stabilizers, has been reported in the United States and globally. In addition, there has been an increase in the production and usage of illicit PADs and emergence of new psychoactive substances (NPSs) all over the world.
Prisco L., Sarwal A., Ganau M., Rubulotta F.   +3 more
openaire   +4 more sources

Novel psychoactive substances [PDF]

British Journal of General Practice, 2016
Gilani does well to highlight the increasing and concerning use of novel psychoactive substances (NPS) in the UK.1 We have seen the damaging and unpredictable effects of synthetic cannabinoids in prisons …
L. Orsolini, D. Papanti, R. Vecchiotti, A. Valchera, J. Corkery, F. Schifano   +5 more
openaire   +3 more sources

The Use and Impact of Cognitive Enhancers among University Students: A Systematic Review

Brain Sciences, 2021
Introduction: Cognitive enhancers (CEs), also known as “smart drugs”, “study aids” or “nootropics” are a cause of concern. Recent research studies investigated the use of CEs being taken as study aids by university students.
Safia Sharif, Amira Guirguis, Suzanne Fergus, Fabrizio Schifano   +3 more
doaj   +1 more source

GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach

Brain Sciences, 2023
The emergence of glucagon-like peptide-1 receptor agonists (GLP-1 RAs; semaglutide and others) now promises effective, non-invasive treatment of obesity for individuals with and without diabetes.
Davide Arillotta, Giuseppe Floresta, Amira Guirguis, John Martin Corkery, Valeria Catalani, Giovanni Martinotti, Stefano L. Sensi, Fabrizio Schifano   +7 more
doaj   +1 more source

Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach

Frontiers in Psychiatry, 2021
COVID-19-related disruptions of people and goods' circulation can affect drug markets, especially for new psychoactive substances (NPSs). Drug shortages could cause a change in available NPS, with the introduction of new, unknown, substances. The aims of
Valeria Catalani, Davide Arillotta, John Martin Corkery, Amira Guirguis, Amira Guirguis, Alessandro Vento, Alessandro Vento, Alessandro Vento, Fabrizio Schifano   +8 more
doaj   +1 more source

COVID-19 Pandemic Impact on Substance Misuse: A Social Media Listening, Mixed Method Analysis

Brain Sciences, 2021
The restrictive measures adopted during the COVID-19 pandemic modified some previously consolidated drug use patterns. A focus on social networks allowed drug users to discuss, share opinions and provide advice during a worldwide emergency context.
Davide Arillotta, Amira Guirguis, John Martin Corkery, Norbert Scherbaum, Fabrizio Schifano   +4 more
doaj   +1 more source

The Psychonauts’ Benzodiazepines; Quantitative Structure-Activity Relationship (QSAR) Analysis and Docking Prediction of Their Biological Activity

Pharmaceuticals, 2021
Designer benzodiazepines (DBZDs) represent a serious health concern and are increasingly reported in polydrug consumption-related fatalities. When new DBZDs are identified, very limited information is available on their pharmacodynamics.
Valeria Catalani, Michelle Botha, John Martin Corkery, Amira Guirguis, Alessandro Vento, Norbert Scherbaum, Fabrizio Schifano   +6 more
doaj   +1 more source

A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases

Pharmaceuticals, 2022
Despite increasing reports, antidepressant (AD) misuse and dependence remain underestimated issues, possibly due to limited epidemiological and pharmacovigilance evidence.
Stefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, John Martin Corkery, Giovanni Martinotti, Fabrizio Schifano   +5 more
doaj   +1 more source

The use of psychoactive substances in Germany

Deutsches Ärzteblatt international, 2022
Monitoring the use of psychoactive substances and substance-related problems in the population allows for the assessment of prevalence and associated health and social consequences.The data are derived from the Epidemiological Survey of Substance Abuse (ESA) 2021 (n = 9046, 18-64 years).
Christian, Rauschert, Justin, Möckl, Nicki-Nils, Seitz, Nicolas, Wilms, Sally, Olderbak, Ludwig, Kraus   +5 more
openaire   +2 more sources

Herbal highs: review on psychoactive effects and neuropharmacology [PDF]

, 2017
Background: A new trend among users of new psychoactive substances’ the consumption of “herbal highs”: plant parts containing psychoactive substances.
Graziano, S, Orsolini, L, Pichini, S., Rotolo, Mc, Schifano, F, Tittarelli, R   +5 more
core   +1 more source